Rapamycin cream: topical sirolimus for skin aging
Topical rapamycin cream reduces skin senescence, boosts collagen, and visibly improves aging skin. Here's the science, dosing, and how to get it.
Most anti-aging skincare works by masking. Retinol tells cells to work harder. Peptides signal collagen production. Antioxidants mop up free radicals. These approaches are useful. But none of them actually address why skin ages at the molecular level.
Rapamycin cream does something different. It targets the root driver of cellular aging in skin: senescence. And the clinical results, while still early, are striking enough that longevity researchers and biohackers have been paying close attention.
This is what you need to know about topical rapamycin, from the science to the sourcing, what results look like, and who it actually makes sense for.
What is rapamycin, and why would you put it on your skin?
Rapamycin is a compound first discovered in soil bacteria from Easter Island (Rapa Nui, which gives it its name). It's an mTOR inhibitor, and mTOR (mechanistic target of rapamycin) is one of the central regulators of cell growth, metabolism, and aging across nearly every organism studied.
When researchers figured out that mTOR signaling drives many of the cellular processes associated with aging, rapamycin became one of the most interesting molecules in longevity research. It's FDA-approved as an oral immunosuppressant for organ transplant patients, and it's been used off-label for longevity purposes in low intermittent doses for years. WinAging's guide to how to buy rapamycin covers the oral route in detail.
But skin aging involves a specific problem that topical application can address directly: the accumulation of senescent cells in the dermis and epidermis.
The senescence problem in aging skin
Senescent cells are cells that have permanently stopped dividing. They accumulate with age. And crucially, they don't just sit there quietly. They secrete a cocktail of inflammatory signals called the senescence-associated secretory phenotype, or SASP. This chronic low-level inflammation degrades the surrounding tissue, impairs collagen production, disrupts the skin's structural integrity, and accelerates the aging of neighboring healthy cells.
The protein p16INK4A is one of the clearest markers of cellular senescence. Young skin has low p16 levels. Aging skin has high levels. And this correlates directly with the visible signs of skin aging: wrinkles, loss of volume, reduced elasticity, age spots, and the general thinning that makes older skin look fragile.
Rapamycin doesn't just suppress inflammation symptoms. It addresses the upstream driver. By inhibiting mTOR, it suppresses what researchers call "geroconversion," the process by which cells in a transient arrested state convert into permanent senescent cells. Fewer senescent cells means less SASP, less chronic inflammation, and a tissue environment that stays younger for longer.
How does mTOR fit into this?
Here's the mechanism that makes rapamycin uniquely interesting for skin: when the cell cycle is blocked (which happens as cells age and accumulate DNA damage), mTOR keeps pushing cells toward growth. But since they can't divide, that growth-like signaling tips them into senescence instead.
Rapamycin breaks that cycle. It allows cells in a stress-arrested state to stay there without converting to full senescence. The effect is essentially preserving cells in a younger, more reversibly arrested state rather than pushing them into the permanent senescent state that damages surrounding tissue.
This is categorically different from what retinol, peptides, or growth factors do. Those approaches work on top of the senescent cell problem. Rapamycin works under it.
The key clinical study
The landmark study on topical rapamycin came out of Drexel University in 2019 and was published in GeroScience. It was a placebo-controlled trial where participants applied either rapamycin cream or placebo to the back of one hand daily for eight months.
The results were measurable at both the molecular and clinical level.
Molecular findings: p16INK4A protein levels dropped by roughly 50% in the rapamycin-treated hands compared to placebo. Collagen VII levels increased, which is important because collagen VII is what anchors the outer layer of skin to the deeper dermis. Lose collagen VII and skin loses structural integrity. Gain it back and skin looks and feels more substantial.
Clinical findings: Skin photoaging improved. Skin tone became more even. Fine wrinkles decreased. Dermal volume increased. Sagging was reduced. And these differences were detectable within four months of consistent use.
This isn't a laboratory study in cells or mice. These are measured outcomes in human skin, with a control group, observed over eight months. That's meaningful.
What the study didn't do is give us long-term data over years or compare rapamycin directly to standard treatments like tretinoin in a head-to-head trial. That research is still developing. But for an early-stage clinical result, the signal is strong enough to take seriously.
Rapamycin cream vs retinol and tretinoin
Let's be honest about where the evidence stands. Tretinoin (prescription retinoid) has decades of clinical data behind it. It's the most evidence-backed topical anti-aging treatment that exists. If you're choosing between starting with tretinoin or starting with rapamycin, tretinoin has more proven benefit across larger populations studied over longer periods.
But rapamycin works through a completely different mechanism. And that makes the question not "which is better" but rather "can they complement each other."
Retinoids work by binding retinoic acid receptors in cells, which upregulates genes involved in collagen production and cell turnover. It essentially pushes cells to work harder. That can cause irritation, dryness, and peeling, especially at higher concentrations. And it works regardless of whether cells are senescent or not. It asks all cells to produce more.
Rapamycin targets senescent cells specifically. It doesn't accelerate turnover in the same way, which means its irritation profile is genuinely mild. Dry skin is the most commonly reported side effect, typically mild and resolving within a week or two. There's no significant redness, peeling, or photosensitivity on the level you'd see with aggressive retinoid protocols.
For people who tolerate tretinoin poorly, rapamycin is a meaningful alternative that works upstream in the aging process. For people already using tretinoin successfully, adding rapamycin targets a different pathway that tretinoin doesn't address.
Use the WinAging supplement interaction checker if you're stacking multiple compounds and want to verify there are no concerns with your full longevity stack.
What concentration to use
Topical rapamycin cream is available from compounding pharmacies in multiple concentrations. The most common options are:
0.001% to 0.01%: Very low concentrations used by some compounding pharmacies combining rapamycin with other actives like niacinamide. Empower Pharmacy's Anti-Aging Siro Gel, for instance, uses 0.001% sirolimus with 4% niacinamide.
0.1%: The concentration used in the landmark GeroScience study. This is a reasonable midpoint, enough to drive measurable molecular changes without the concentrations used for clinical skin conditions.
0.25% to 1%: Higher concentrations more typically used for specific dermatological conditions like facial angiofibromas in tuberous sclerosis complex, where more aggressive dosing is needed for treatment.
For general anti-aging use, most prescribing physicians work in the 0.1% to 0.25% range. Some clinics use lower concentrations in combination formulas. The research supporting visible skin improvements was done at 0.1%, so there's no strong rationale to go higher for cosmetic purposes.
Dosing protocol in the study was daily application. Many clinicians suggest applying once daily, in the evening, to clean dry skin. Some protocols suggest starting every other day to assess tolerance, then moving to daily.
Safety profile: what you actually need to know
Topical rapamycin has a genuinely favorable safety profile compared to systemic (oral) rapamycin. The key safety advantages come down to absorption.
When taken orally, rapamycin enters the bloodstream and has systemic effects, including meaningful immunosuppression at transplant doses. That's why oral rapamycin requires careful physician monitoring, especially for longevity use where the off-label dosing protocols are still being refined. Rapamycin cost covers the oral version and what monitoring typically looks like.
Topical rapamycin tells a different story. In clinical studies involving more than 500 blood samples from participants using topical sirolimus, systemic blood levels were undetectable. The skin barrier limits absorption significantly, and the concentrations used for anti-aging applications are small enough that what does get absorbed is physiologically negligible.
The adverse effects in clinical trials were mild and localized:
Most common: Dry skin (usually mild, resolves within a week or two) Occasional: Application site irritation, burning sensation, or redness Rare: These effects are generally comparable to what you'd see with any active skincare ingredient
One practical precaution: use SPF daily when using any active skincare, including rapamycin. Not because rapamycin causes photosensitivity specifically (it doesn't, unlike retinoids), but because sun exposure accelerates the exact skin aging you're trying to reverse, and it's just good practice.
Who shouldn't use it: Women who are pregnant, planning to become pregnant, or breastfeeding should avoid topical rapamycin. There's no specific contraindication evidence for topical use specifically, but the systemic data on rapamycin and fetal development warrants caution. If you're on an oral mTOR inhibitor for any reason, check with your prescribing physician before adding topical rapamycin.
There's also a theoretical concern about long-term cancer risk with any immunomodulating compound. The topical data doesn't show elevated cancer risk, and systemic absorption is minimal. But it's worth having a frank conversation with a prescribing physician, particularly if you have a personal or family history of skin cancer.
How to get rapamycin cream: what's actually required
Here's the straightforward reality: rapamycin cream requires a prescription in the United States. It's not available over the counter and not available without physician oversight. This is a meaningful constraint compared to retinol or peptide serums, which you can buy from any pharmacy shelf.
The process typically looks like this:
Step 1: Find a physician willing to prescribe topical rapamycin for anti-aging. This is more common than it used to be. Longevity-oriented physicians and some dermatologists who stay current with the research will consider it. Telehealth platforms focused on longevity medicine (Healthspan, Heally, and similar services) are increasingly prescribing it.
Step 2: The physician evaluates your health profile and determines whether you're an appropriate candidate.
Step 3: You receive a prescription for a specific concentration and formulation, sent to a compounding pharmacy.
Step 4: The compounding pharmacy prepares your rapamycin cream and ships it directly.
The compounding pharmacies most commonly used for this purpose include Empower Pharmacy, Bayview Pharmacy, and CFS Pharmacy, among others. Prices vary, but a monthly supply typically runs in the $60 to $120 range depending on concentration and formulation.
This is meaningfully more expensive than buying retinol at the drugstore, but it's in the same ballpark as higher-end skincare products from brands like SkinCeuticals or prescription tretinoin through a dermatologist. For people optimizing their longevity stack, it's a different category of intervention.
Who is rapamycin cream actually for?
Be honest with yourself about the target audience here. Rapamycin cream is not a replacement for sunscreen, moisturizer, or the basics that protect skin every day. It's an add-on for people already doing those things who want to address the cellular aging mechanisms that conventional skincare can't touch.
It makes the most sense for:
People in their 40s or older with visible signs of skin aging who are interested in longevity science and comfortable working with a physician on evidence-based interventions. People who have tried retinoids and experienced significant irritation. People already taking oral rapamycin for longevity who want to understand whether topical application offers additive benefits for the skin specifically. And people building serious longevity protocols who want to address the full picture, not just what's visible in the mirror.
It's probably not necessary if:
You're in your 20s or early 30s with minimal skin aging signs. You haven't established the basics: sun protection, quality sleep, adequate hydration, diet quality. These foundations drive far more of your skin health than any active ingredient.
WinAging covers the full longevity supplement landscape, including compounds that support skin health through systemic mechanisms like glycine (which supports collagen production), glycine dosage for anti aging, and the broader picture of how internal longevity compounds interact with skin aging over time.
Where rapamycin cream fits in a longevity skincare stack
If you're building a comprehensive approach, topical rapamycin works best alongside other evidence-based interventions rather than as a standalone treatment.
A reasonable layered approach:
Foundation: SPF 30+ broad-spectrum sunscreen daily. This is non-negotiable. UV damage is the single largest driver of visible skin aging, and no amount of actives will outpace ongoing UV exposure without protection.
Established actives: Tretinoin (if tolerated) or retinol for collagen stimulation and cell turnover. Niacinamide for barrier support, evening of skin tone, and anti-inflammatory effects. Vitamin C serum for antioxidant protection and collagen synthesis.
Senescence targeting: Topical rapamycin at 0.1% to 0.25%, applied in the evening on alternating days to start, moving to daily as tolerated.
Systemic support: Compounds that support skin health through internal mechanisms. Collagen peptides and glycine support the production side of the equation. Berberine's metabolic effects improve the tissue environment broadly. If you're building out a supplement stack, use the supplement interaction checker to verify your combinations before adding to your routine. The biological age calculator can help you track whether your overall protocol is moving your biological markers in the right direction.
Can you use rapamycin cream and tretinoin together? Yes. They work on different pathways. Rapamycin targets senescent cells upstream. Tretinoin drives cell turnover and collagen synthesis. Some people apply tretinoin on one evening, rapamycin the next, to minimize any cumulative irritation risk. Others use both. Your skin's response will tell you what it can handle.
What to expect: timeline and results
Managing expectations matters. Rapamycin cream is not a dramatic overnight intervention. The clinical trial showed measurable changes at four months and clear results at eight months of consistent daily use. This is a gradual process because cellular aging itself is gradual.
What the research suggests you might see with consistent use over several months:
Improvement in skin tone and texture. This tends to be one of the earlier visible changes. The underlying changes in skin structure, more collagen VII, less chronic inflammation, take time to manifest visually.
Reduction in fine lines. Not deep structural wrinkles (no topical product reliably reverses those), but the fine textural lines associated with dehydration and surface cell quality.
Improved firmness and density. The increase in dermal volume observed in the study translates to skin that feels more substantial, less paper-thin.
Reduction in some age spots. p16-positive senescent cells contribute to the inflammatory signals that drive hyperpigmentation. Reducing their burden has some effect on uneven pigmentation, though this is more a secondary benefit than a primary mechanism.
Give it six months of consistent use before evaluating whether it's working for you. Track it, if you can. Photographs under consistent lighting conditions every four weeks give you an objective basis for comparison. Skin changes are gradual enough that they're hard to notice day to day but visible when you compare photos six months apart.
The research frontier: what comes next
The field of topical rapamycin research is still young. The 2019 GeroScience trial was exploratory and involved a small number of participants. The results were promising but this is not the level of evidence we'd want before making a major clinical recommendation.
What researchers are working on now includes larger randomized controlled trials with more participants, longer follow-up periods (beyond eight months), direct comparisons against established anti-aging topicals like tretinoin, and studies examining different concentrations and formulations.
A 2024 systematic review in The Lancet Healthy Longevity reaffirmed the earlier findings: topical rapamycin significantly reduced markers of skin aging. But systematic reviews of small trials still have limitations. More and larger studies are coming.
The related work on oral rapamycin for systemic longevity is also relevant. The PEARL trial and other ongoing studies are generating data on how mTOR inhibition affects aging across multiple tissues. As that evidence base grows, it'll inform how we think about the topical form as well.
Frequently asked questions
Is rapamycin cream safe to use long-term?
The current evidence suggests yes, with an important caveat: the available data extends to about eight months in anti-aging trials, and longer-term studies are still ongoing. Short-term safety is well-established. Systemic absorption is minimal and blood levels remain undetectable in clinical settings. The most important thing is working with a physician who monitors your use over time.
Can rapamycin cream cause immunosuppression?
At the concentrations and formulations used for topical anti-aging (typically 0.1% to 0.25%), systemic absorption is low enough that immunosuppression is not a clinical concern. This is categorically different from oral rapamycin, which at transplant doses does significantly suppress the immune system. The topical route bypasses most of this risk.
How does rapamycin cream compare to oral rapamycin for longevity?
They serve different purposes. Oral rapamycin targets systemic aging processes throughout the body. Topical rapamycin targets skin-specific aging at the site of application. For people building a longevity protocol, they can complement each other. Some longevity physicians who prescribe oral rapamycin also add topical rapamycin for patients interested in skin-specific benefits.
Do I need a prescription?
Yes, in the United States, topical rapamycin requires a prescription. It's not available over the counter. Telehealth platforms focused on longevity medicine have made the prescription process more accessible, but physician oversight is required.
Can I make rapamycin cream at home?
No. Compounding rapamycin into a stable, properly concentrated topical formulation requires pharmaceutical expertise. Attempting to dissolve rapamycin tablets or raw compound into a cream at home risks incorrect concentration, unstable formulation, or contamination. Get it from a licensed compounding pharmacy with a valid prescription.
How much does rapamycin cream cost?
Compounded topical rapamycin typically runs $60 to $120 per month depending on concentration, formulation, and pharmacy. The consultation to get the prescription, if you don't already have a prescribing physician, adds to the initial cost. Some telehealth platforms include this in a monthly subscription that covers both the prescription and the medication.
Is rapamycin cream the same as the drug rapamycin used for transplants?
Same molecule, different delivery method and concentration. Rapamycin (sirolimus) is FDA-approved for organ transplant immunosuppression at oral doses that systemically suppress the immune system. Topical formulations use very low concentrations applied to the skin, with minimal systemic absorption, for an entirely different purpose.
How long before I see results?
In the clinical trial, measurable differences appeared within four months. Visible clinical improvements were clear by eight months. Give it at least four to six months of consistent use before drawing conclusions.
Rapamycin cream sits at the edge of what's proven and what's emerging. The mechanism is compelling, the early clinical data is genuinely promising, and the safety profile at topical concentrations is favorable. But it's still a relatively new approach with a limited evidence base compared to decades of tretinoin research.
If you're building a serious longevity protocol and already have the foundations in place, adding topical rapamycin is a reasonable next step for skin-specific aging. Start with a conversation with a longevity-oriented physician, use a reputable compounding pharmacy, and be patient with the timeline.
Explore the free longevity tools at WinAging to build the rest of your protocol with the same rigor.
Looking for a complete protocol, not just one compound? The WinAging protocol builder creates personalized longevity stacks based on your specific goals and health profile.
Related guides
- How to buy rapamycin
- Rapamycin cost: what you'll actually pay
- Glycine dosage for anti-aging
- Supplement interaction checker
